... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Stress cardiomyopathy Broken heart syndrome Biomarker During the last 2...

...Helge Røsjø; Ole Geir Solberg; Lars Aaberge; Gerhard Bosse; Torbjørn Omland; Knut Stavem; Peder L. Myhre Introduction: Secretoneurin (SN) is a novel biomarker that provides prognostic information in patients with cardiovascular disease. In experimental models, SN production is increased...

...Marie-Hélène Grazide; Jean-Bernard Ruidavets; Wim Martinet; Meyer Elbaz; Cécile Vindis Introduction: Acute myocardial infarction (AMI) is a main contributor of sudden cardiac death worldwide. The discovery of new biomarkers that can improve AMI risk prediction meets a major clinical need...

...Wangge Ma; Wei Zhang; Huahua Liu; Benheng Qian; Rongguang Lai; Zijun Yao; Yidong Wang; Yang Yan; Zuyi Yuan Introduction: Calcific aortic valve disease (CAVD) is the third most common cardiovascular disease in aging populations. Despite a growing number of biomarkers having been shown...

... with preserved ejection fraction Prognosis Biomarker Thyroid hormones (THs) are crucial for the homeostasis of the cardiovascular system [ 1 ]. THs comprise thyroxine (T4) and triiodothyronine (T3), the latter being the most active form. Peripheral conversion of T4 to T3 by type 1 and type 2...

...Hongjie Chi; Haijun Feng; Xiangyu Shang; Jie Jiao; Lanlan Sun; Wei Jiang; Xianchen Meng; Yifan Fan; Xiangmin Lin; Jiuchang Zhong; Xinchun Yang Background: Connective tissue growth factor (CTGF) and transforming growth factor β1 (TGF-β1) are emerging biomarkers for tissue fibrosis. The aim...

... variability increased, with a marked increase up to about 30%. Conclusions: Even in the stable phase of CHF, V2V-BNP variability was associated with worse long-term outcomes, independent of BNP level. [email protected] 21 02 2019 6 05 2019 22 7 2019 Heart failure Biomarker...

... type IV collagenase, is expressed in atherosclerotic plaques and plays a pathogenic role in the rupture and vulnerability of atherosclerotic plaques; therefore, MMP-9 can be regarded as a biomarker of plaque vulnerability [ 12,14 ]. The aim of the present study was to clarify the usefulness of MMP...

... ventricular remodeling (LVR). This study assessed whether miR-146a, miR-21 and other biomarkers could predict LVR after myocardial infarction (MI). Methods: Circulating miR-146a, miR-21 and other biomarker levels were measured in 198 patients with acute MI 5 days after primary percutaneous coronary...

...Maarten de Mulder; Tjeerd van der Ploeg; Guus A. de Waard; Eric Boersma; Victor A. Umans Objective: Admission plasma glucose (APG) is a biomarker that predicts mortality in myocardial infarction (MI) patients. Therefore, APG may improve risk stratification based on the GRACE risk score. Methods: We...

...Olof Gidlöf; Patrik Andersson; Jesper van der Pals; Matthias Götberg; David Erlinge Objectives: Circulating microRNAs (miRNAs) are promising as biomarkers for various diseases. We examined the release patterns of cardiospecific miRNAs in a closed-chest, large animal ischemia-reperfusion model...

...Jin-Sun Kim; Hye Jin Hwang; Young-Guk Ko; Jung-Sun Kim; Donghoon Choi; Jong-Won Ha; Myeong-Ki Hong; Yangsoo Jang Objectives: We investigated whether ischemia-modified albumin (IMA), a novel biomarker of acute myocardial ischemia, is reliable for diagnosing ischemic chest pain and predicting future...